ROSSETTI, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 201
EU - Europa 152
AS - Asia 97
SA - Sud America 31
AF - Africa 2
OC - Oceania 1
Totale 484
Nazione #
US - Stati Uniti d'America 197
SG - Singapore 67
IE - Irlanda 52
RU - Federazione Russa 32
BR - Brasile 26
DE - Germania 23
IT - Italia 20
HK - Hong Kong 14
CN - Cina 9
FI - Finlandia 6
BE - Belgio 4
GB - Regno Unito 3
NL - Olanda 3
CA - Canada 2
CZ - Repubblica Ceca 2
UA - Ucraina 2
VE - Venezuela 2
AT - Austria 1
AU - Australia 1
BG - Bulgaria 1
EC - Ecuador 1
EG - Egitto 1
GT - Guatemala 1
IL - Israele 1
JP - Giappone 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LT - Lituania 1
NG - Nigeria 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PL - Polonia 1
SE - Svezia 1
TR - Turchia 1
UY - Uruguay 1
VN - Vietnam 1
Totale 484
Città #
Chandler 57
Dublin 48
Singapore 38
Ashburn 18
New York 16
Santa Clara 16
Hong Kong 14
Boardman 10
Munich 10
Moscow 9
Bremen 6
Lawrence 6
Princeton 6
Helsinki 5
Los Angeles 5
L’Aquila 5
Ann Arbor 4
Brussels 4
Cagliari 4
Jacksonville 4
Rome 4
Dallas 3
Des Moines 3
Amsterdam 2
Belo Horizonte 2
Berlin 2
Brno 2
Curitiba 2
Falkenstein 2
Falls Church 2
Frankfurt am Main 2
Garland 2
Menlo Park 2
Milan 2
Pescara 2
Seattle 2
Toronto 2
Agrolândia 1
Almaty 1
Antakya 1
Araçatuba 1
Bishkek 1
Brasópolis 1
Cairo 1
Campinas 1
Capelinha 1
Caracas 1
Caruaru 1
Cascavel 1
Catanduva 1
Cedar Knolls 1
Chieti 1
Council Bluffs 1
Edinburgh 1
Fairfield 1
Fenghua 1
Garanhuns 1
Guatemala City 1
Hamburg 1
Hanoi 1
Houston 1
Indaiatuba 1
Jacareí 1
Kaifeng 1
Kardzhali 1
Kyiv 1
Lagos 1
Lappeenranta 1
Lauro de Freitas 1
Leopoldina 1
Macapá 1
Mallet 1
Manila 1
Maracaibo 1
Montevideo 1
Norwalk 1
Palermo 1
Panama City 1
Parauapebas 1
Passo Fundo 1
Posse 1
Quito 1
Rio de Janeiro 1
Ryazan 1
San Diego 1
San Juan de Lurigancho 1
Shijiazhuang 1
Sydney 1
São Tiago 1
Tel Aviv 1
Teramo 1
Tokyo 1
Vale do Sol 1
Venda Nova do Imigrante 1
Vienna 1
Warsaw 1
Washington 1
Wilmington 1
Totale 384
Nome #
Clinically relevant radioresistant rhabdomyosarcoma cell lines: Functional, molecular and immune-related characterization 89
ATX-101, a Peptide Targeting PCNA, Has Antitumor Efficacy Alone or in Combination with Radiotherapy in Murine Models of Human Glioblastoma 67
Multiple Antitumor Molecular Mechanisms Are Activated by a Fully Synthetic and Stabilized Pharmaceutical Product Delivering the Active Compound Sulforaphane (SFX-01) in Preclinical Model of Human Glioblastoma 62
The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Is Synergistic With Radiotherapy in Models of Human Glioblastoma 60
Ms−275 (Entinostat) promotes radio-sensitivity in pax3-foxo1 rhabdomyosarcoma cells 52
Romidepsin (FK228) fails in counteracting the transformed phenotype of rhabdomyosarcoma cells but efficiently radiosensitizes, in vitro and in vivo, the alveolar phenotype subtype 50
The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Inhibits Growth of Human Glioblastoma, Reduces Akt/mTOR Activities, and Modulates GSC Cell-Renewal Properties 40
Caratterizzazione funzionale e molecolare di inibitori farmacologici ad attività anti-istone-deacetilasica, in modelli in vitro ed in vivo di Rabdomiosarcoma 38
General Direct Anticancer Effects of Deer Growing Antler Extract in Several Tumour Cell Lines, and Immune System-Mediated Effects in Xenograft Glioblastoma 15
A Pharmacological Investigation of Eph-Ephrin Antagonism in Prostate Cancer: UniPR1331 Efficacy Evidence 12
The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo 11
Antitumour effects of SFX-01 molecule in combination with ionizing radiation in preclinical and in vivo models of rhabdomyosarcoma 8
Totale 504
Categoria #
all - tutte 2.840
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.840


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 2 1 0 2 0 1 0 2 0
2021/202239 0 1 0 1 1 0 2 1 10 10 2 11
2022/2023145 7 13 2 22 12 18 0 10 54 1 5 1
2023/202484 6 1 3 2 2 29 8 10 0 3 8 12
2024/2025228 7 7 15 23 16 21 43 29 62 5 0 0
Totale 504